Skip to main content

Together we are beating cancer

Donate now

Justine Alford

Justine studied biological sciences at the University of Warwick before diving straight into a PhD at the same institution, working on how HIV hijacks certain transport pathways in cells. After subsequently working as a science writer for several years, Justine joined the Science Communications team at Cancer Research UK in 2016, helping communicate research on cancer to the public and media.
Showing 12 out of 81 results
This entry is part 26 of 30 in the series Our milestones

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t. New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

by Justine Alford | Analysis | 27 June 2017

27 June 2017

8 new Grand Challenges in cancer research launched, blood tests for prostate cancer, making immunotherapy more personal and… ‘go natural’? Here’s our weekly news digest. 8 new Grand Challenges in cancer research launched, blood tests for prostate cancer, making immunotherapy more personal and… ‘go natural’? Here’s our weekly news digest.

by Justine Alford | Analysis | 24 June 2017

24 June 2017

This entry is part 2 of 23 in the series Science Surgery

Our new series, Science Surgery, gives you the opportunity to ask us questions about cancer science and research. Our new series, Science Surgery, gives you the opportunity to ask us questions about cancer science and research.

by Justine Alford | Analysis | 26 May 2017

26 May 2017

This entry is part 1 of 23 in the series Science Surgery

Fewer vapers are smoking cigarettes, ‘carbon-dating’ cancer spread and... gardening to tackle childhood obesity? Here’s our weekly news digest. Fewer vapers are smoking cigarettes, ‘carbon-dating’ cancer spread and... gardening to tackle childhood obesity? Here’s our weekly news digest.

by Justine Alford | Analysis | 13 May 2017

13 May 2017

In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up. In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up.

by Justine Alford | Analysis | 11 April 2017

11 April 2017